Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Nicotine is a stimulatory alkaloid found in tobacco products that is often used for the relief of nicotine withdrawal symptoms and as an aid to smoking cessation. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission.
- Mechanism
- Curator reviewed
Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed up of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible the euphoric and addictive properties of nicotine. Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing influx of sodium, causing depolarization of the cell, which activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar.
- Primary indication
- For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.Curator reviewed · 1 structured indication
- Formula / weight
- C10H14N2 · 162.2316 g/mol (avg)
- First approval
- Canada, 2011 · United States, 1990
- Also known as
- (S)-Nicotine · Nicotine betadex · Nicotine polacrilex
- Brand names
- Habitrol
- Nicoderm C-Q
- Nicorelief
- Nicorette
- Nicotrol
Resolves to
SNICXCGAKADSCV-JTQLQIEISA-NSMILESCN1CCC[C@H]1C1=CN=CC=C1What you can answer from here — as of September 29, 2026
Which drugs share a target with Nicotine, and which of those have an active Phase 3 trial?